Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Aug 22, 2013

Keywords

ClinConnect Summary

This clinical trial is studying the effects of chest physiotherapy on lung function in patients with a rare condition called primary ciliary dyskinesia (PCD). PCD affects the tiny hair-like structures in the body that help clear mucus from the lungs, leading to frequent respiratory infections. The researchers want to understand if chest physiotherapy, a treatment that helps clear mucus from the lungs, can improve how well the lungs work both in the short and long term. They believe that having a session of this therapy might lead to better lung function, so they will conduct tests in a consistent way to measure this.

To participate in the trial, individuals must be diagnosed with primary ciliary dyskinesia and be at least 6 years old, as they need to be able to perform specific lung tests. However, those currently experiencing a severe flare-up of their condition will not be eligible. Participants will receive chest physiotherapy and undergo lung function tests to see how the therapy affects their breathing. The trial is currently recruiting participants of all genders, and it aims to provide valuable insights that could help improve treatment for people with PCD.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Primary ciliary dyskinesia
• • able to perform spirometry and MBW (\>6 years)
• Exclusion Criteria:
• • acute exacerbation